• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Psychiatry

Dog ownership may reduce loneliness and depression during the COVID-19 pandemic

byKiera LiblikandAvneesh Bhangu
April 10, 2022
in Psychiatry, Wellness
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. This observational study found that dog owners reported significantly lower social isolation and depression compared to non-dog owners.

2. However, anxiety and perceived happiness scores did not vary significantly between groups.

Evidence Rating Level: 2 (Good)

The coronavirus disease 2019 (COVID-19) pandemic has resulted in the implementation of public health measures limiting social interaction. Notably, loss of social support is a risk factor for decreased mental wellness. Dogs (Canis familiaris) are routinely used as a therapeutic aid to provide social support to patients in long-term and pediatric care. Accordingly, their companionship may reduce feelings of social isolation and associated mental health consequences during COVID-19.

This observational study aimed to delineate the impact of dog ownership on mental wellbeing during a global crisis, the COVID-19 pandemic. Participants were included who were >18 years of age, spoke English, were able to use a computer, and living in the United States. Individuals who owned an animal other than a dog were excluded from the study. Recruitment was conducted by a third-party research agency during November of 2020. Mental wellbeing was assessed with the Multidimensional Scale of Perceived Social Support (MSPSS), Center for Epidemiologic Studies Depression Scale-Revised (CESD-R), Generalized Anxiety Disorder Scale (GAD-7), and Oxford Happiness Questionnaire (OHQ).

In total, 1535 participants completed the survey with 768 in the dog owner group and 767 controls without pets. Dog owners reported significantly lower depression scores (p=0.018) than the control group as well as increased perceived social support (p=0.042). Alternatively, no significant difference was seen between groups in anxiety (p=0.186) and happiness scores (p=0216). However, the study results may not be generalizable as only individuals in the United States were recruited and may have been under different COVID-19 restrictions depending on their state of residence. Nonetheless, this study demonstrated that dog ownership may help mitigate the impact of emotional distress of social isolation.

RELATED REPORTS

Federal Drug Administration approves Alzheimer’s blood test for use in primary care

Self-Help App for Depression in People With Intellectual Disabilities: A Randomized Clinical Trial

2 Minute Medicine Rewind October 13, 2025

Click to read the study in PLOS ONE

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anxietydepressiondoglonelinessmental healthwellness
Previous Post

Wellness Check: Mental Health

Next Post

Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis – the ASCEND-ID trial

RelatedReports

FDA-regulated clinical trials rarely report violations
The Scan by 2 Minute Medicine®

Federal Drug Administration approves Alzheimer’s blood test for use in primary care

October 22, 2025
Shared decision-making tool for antidepressants improves patient and physician satisfaction
Chronic Disease

Self-Help App for Depression in People With Intellectual Disabilities: A Randomized Clinical Trial

October 16, 2025
Weekly Rewinds

2 Minute Medicine Rewind October 13, 2025

October 13, 2025
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Obstetrics

The Scan by 2 Minute Medicine®: Leucovorin autism update, Oura Ring FDA scrutiny, Lilly oral GLP-1 trial, and Florida vaccine mandate repeal

September 25, 2025
Next Post
Being overweight and obese associated with increased incidence of chronic kidney disease

Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis – the ASCEND-ID trial

#VisualAbstract: Adding four doses of rituximab did not significantly improve event-free survival over standard of care in acute lymphoblastic leukaemia

#VisualAbstract: Adding four doses of rituximab did not significantly improve event-free survival over standard of care in acute lymphoblastic leukaemia

Compliance-linked incentives increase infant immunizations rates in rural India

2 Minute Medicine Rewind April 11, 2022

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Hearing Loss, Brain Structure, Cognition, and Dementia Risk in the Framingham Heart Study
  • Hysterectomy Status and Outcomes in Patients With Grade 1, Stage IA Endometrioid Adenocarcinoma 
  • Risk of cardiovascular mortality in patients with gastric cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.